Turbine Simulated Cell Technologies
@turbine-ai.bsky.social
Turbine is virtualizing experiments with AI to accelerate discovery and clinical decisions. By simulating how cells and tissues behave under treatment, Turbine helps pharma identify the right therapeutic ideas smarter and faster.
200+ live for our series kickoff! 🚀
Huge thanks to everyone who joined our Virtual Biology Community Meetup yesterday.
Missed it? Catch the replay: 📺 youtu.be/ptMy4yhZT8Q
#virtualbiology #decodingbiology #virtualcell #virtualizeexperiments #aiforbiology #drugdiscovery
Huge thanks to everyone who joined our Virtual Biology Community Meetup yesterday.
Missed it? Catch the replay: 📺 youtu.be/ptMy4yhZT8Q
#virtualbiology #decodingbiology #virtualcell #virtualizeexperiments #aiforbiology #drugdiscovery
Virtual Biology Community Meetup
YouTube video by Turbine Simulated Cell Technologies
youtu.be
January 20, 2026 at 4:28 PM
200+ live for our series kickoff! 🚀
Huge thanks to everyone who joined our Virtual Biology Community Meetup yesterday.
Missed it? Catch the replay: 📺 youtu.be/ptMy4yhZT8Q
#virtualbiology #decodingbiology #virtualcell #virtualizeexperiments #aiforbiology #drugdiscovery
Huge thanks to everyone who joined our Virtual Biology Community Meetup yesterday.
Missed it? Catch the replay: 📺 youtu.be/ptMy4yhZT8Q
#virtualbiology #decodingbiology #virtualcell #virtualizeexperiments #aiforbiology #drugdiscovery
High benchmark scores don’t mean your virtual cell is useful.
Read our note - Assessing a Virtual Cell’s Utility: eu1.hubs.ly/H0qR44M0
Substack version: eu1.hubs.ly/H0qQZ6m0
Read our note - Assessing a Virtual Cell’s Utility: eu1.hubs.ly/H0qR44M0
Substack version: eu1.hubs.ly/H0qQZ6m0
Science
eu1.hubs.ly
January 9, 2026 at 5:44 PM
High benchmark scores don’t mean your virtual cell is useful.
Read our note - Assessing a Virtual Cell’s Utility: eu1.hubs.ly/H0qR44M0
Substack version: eu1.hubs.ly/H0qQZ6m0
Read our note - Assessing a Virtual Cell’s Utility: eu1.hubs.ly/H0qR44M0
Substack version: eu1.hubs.ly/H0qQZ6m0
We’re proud to share that Turbine is partnering with MSD (Merck & Co., Inc., Rahway NJ, USA) to unlock new possibilities in the fight against hard-to-treat cancers.
💥 Check out the full press release below for more details: turbine.ai/announcement...
💥 Check out the full press release below for more details: turbine.ai/announcement...
Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD
Explore the future of cancer research with cell simulation technology, used by MSD-Discover how AI is transforming patient population.
turbine.ai
August 4, 2025 at 10:11 AM
We’re proud to share that Turbine is partnering with MSD (Merck & Co., Inc., Rahway NJ, USA) to unlock new possibilities in the fight against hard-to-treat cancers.
💥 Check out the full press release below for more details: turbine.ai/announcement...
💥 Check out the full press release below for more details: turbine.ai/announcement...
🚀 The new era of ADC payload prediction starts now. Step inside the interactive tour of our digital lab next week for a peek behind the curtains!
February 27, 2025 at 6:15 PM
🚀 The new era of ADC payload prediction starts now. Step inside the interactive tour of our digital lab next week for a peek behind the curtains!
💡ADC development remains full of pitfalls: high failure rates persist ~820 inactive programs and ~110 discontinued, while unstable linkers pose risks, with off-target effects threatening precision.
Read the thoughts of Bernd Seizinger, an ADC expert and member of our Independent Board, to weigh in.
Read the thoughts of Bernd Seizinger, an ADC expert and member of our Independent Board, to weigh in.
February 25, 2025 at 4:15 PM
💡ADC development remains full of pitfalls: high failure rates persist ~820 inactive programs and ~110 discontinued, while unstable linkers pose risks, with off-target effects threatening precision.
Read the thoughts of Bernd Seizinger, an ADC expert and member of our Independent Board, to weigh in.
Read the thoughts of Bernd Seizinger, an ADC expert and member of our Independent Board, to weigh in.